Tanya L. Hoskin

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer”.

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190

N/A

0DataRank · unranked

112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Academic Radiology(2020)10.1016/j.acra.2020.10.020

N/A

0DataRank · unranked

62 citations

Daniel Gomez‐Cardona, Christopher Favazza, Tanya L. Hoskin, Tufia C. Haddad, Matthew P. Goetz +2 more

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01286-7

N/A

0DataRank · unranked

20 citations

Xiaonan Hou, Mary J. Kuffel, Vera J. Suman, Tanya L. Hoskin, Kathryn E. Reinicke +17 more

Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy

Cancer Prevention Research(2020)10.1158/1940-6207.capr-20-0178

N/A

0DataRank · unranked

12 citations

Robert A. Vierkant, Suneetha Kaggal, Tanya L. Hoskin, Marlene H. Frost, Lori A. Denison +8 more

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091

N/A

0DataRank · unranked

41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy (NET) and subsequent prognosis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.580

N/A

0DataRank · unranked

0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

The breast tissue microbiome, stroma, immune cells and breast cancer

Neoplasia(2022)10.1016/j.neo.2022.100786

N/A

0DataRank · unranked

41 citations

Jun Chen, Beiyun Chen, Stephen Johnson, Tanya L. Hoskin, Amy C. Degnim +3 more

Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics

BMC Medical Genomics(2022)10.1186/s12920-022-01355-0

N/A

0DataRank · unranked

20 citations

Aditya Bhagwate, Stacey J. Winham, Melissa Stephens, Brent W. Harker, Samantha J. McDonough +13 more

Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence

Breast Cancer Research(2022)10.1186/s13058-022-01541-z

N/A

0DataRank · unranked

11 citations

Thomas de Bel, Derek C. Radisky, Jennifer M. Kachergus, E. Aubrey Thompson, Amy C. Degnim +18 more

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00387-0

N/A

0DataRank · unranked

18 citations

Jodi M. Carter, Tanya L. Hoskin, Vera J. Suman, Malayannan Subramaniam, Michael J. Emch +22 more

Serum hormone levels and normal breast histology among premenopausal women

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06600-9

N/A

0DataRank · unranked

3 citations

Thomas de Bel, Michael G. Heckman, Launia J. White, Joshua Ogony, Melody Stallings‐Mann +13 more

Towards Defining Morphologic Parameters of Normal Parous and Nulliparous Breast Tissues by Artificial Intelligence

Research Square(2022)10.21203/rs.3.rs-1359557/v1

N/A

0DataRank · unranked

0 citations

Thomas de Bel, Derek C. Radisky, Jennifer M. Kachergus, E. Aubrey Thompson, Amy C. Degnim +18 more

Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics

Research Square(2022)10.21203/rs.3.rs-1428294/v1

N/A

0DataRank · unranked

0 citations

Aditya Bhagwate, Stacey J. Winham, Melissa Stephens, Brent W. Harker, Samantha J. McDonough +13 more

Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07152-2

N/A

0DataRank · unranked

11 citations

Tanya L. Hoskin, Courtney N. Day, Amy K. Schulze, Matthew P. Goetz, Judy C. Boughey +1 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350.v1

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Microcalcifications in benign breast biopsies: association with lesion type and risk

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07448-x

N/A

0DataRank · unranked

4 citations

Heather Hardway, Robert A. Vierkant, Stacey J. Winham, Matthew R. Jensen, Bryan M. McCauley +12 more

Changes in breast cancer risk associated with benign breast disease from 1967 to 2013

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae128

N/A

0DataRank · unranked

2 citations

Karthik Ghosh, Robert A. Vierkant, Stacey J. Winham, Tanya L. Hoskin, Jodi M. Carter +15 more

High-resolution microCT to assess breast microcalcification morphometry by histologic lesion subtype and radiologic classification

Breast Cancer Research and Treatment(2025)10.1007/s10549-025-07792-6

N/A

0DataRank · unranked

0 citations

Santo Maimone, Michael Villalba, Robert A. Vierkant, Stacey J. Winham, Bryan M. McCauley +13 more

Tanya L. Hoskin

Indexed papers

Top data-sharing exemplar

Papers